UNITEDHEALTH CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against UnitedHealth Group Incorporated and Encourages Investors to Contact the Firm
Click here to participate in the action.
According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: (1) UnitedHealth had, for years, engaged in a corporate strategy of denying health coverage in order to boost its profits, and ultimately, its share price; (2) this anti-consumer (and at times unlawful) strategy resulted in regulatory scrutiny (as well as public angst) against UnitedHealth, which ultimately resulted in the murder of Brian Thompson ('Thompson'); (3) animus towards UnitedHealth was such that, subsequent to the murder of Thompson, many Americans openly celebrated his demise, expressed admiration for his accused killer, and/or otherwise demanded that UnitedHealth change its strategy even if they condemned Thompson's killing; (4) the foregoing regulatory and public outrage caused UnitedHealth to change its corporate practices; (5) notwithstanding the foregoing, UnitedHealth recklessly stuck with the guidance it issued the day before Thompson's murder, which was unrealistic considering UnitedHealth's changing corporate strategies; and (6) as a result, defendants' public statements were materially false and/or misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
If you purchased or otherwise acquired UnitedHealth shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at [email protected], telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.
About Bragar Eagel & Squire, P.C.:
Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com . Attorney advertising. Prior results do not guarantee similar outcomes.
Follow us for updates on LinkedIn, X, and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn and X.
Contact Information:
Bragar Eagel & Squire, P.C.Brandon Walker, Esq.Marion Passmore, Esq.(212) 355-4648
[email protected]
www.bespc.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
Why Workiva Stock Rocketed More Than 31% Higher Today
Key Points The company blew past analyst estimates for profitability, and also beat the consensus for revenue. Going forward, it's expecting double-digit improvements on both the top and bottom lines. 10 stocks we like better than Workiva › It's not every day that a stock rises by over 30% in a single session. Enterprise software developer Workiva (NYSE: WK) achieved that feat on Friday, with its share price zooming 32% higher on the day thanks to an extremely well-received quarterly earnings report. That rise was all the more impressive given that it was generally a down day for stocks, with the S&P 500 index closing 1.6% underwater. Meaty growth figures in the second quarter Workiva's revenue for its second quarter was $215 million, representing a sturdy 21% improvement over the same period of 2024. That number was also notably higher than the average analyst estimate of under $209 million. The bulk of this take was from subscription and support revenue, which climbed 23% higher to $198 million. The company also blew past the consensus pundit expectation for non-GAAP (adjusted) net income. That line item rang in at $11 million ($0.19 per share), for a 22% increase over the year-ago result. Analysts had collectively been anticipating only $0.05 per share. Workiva said that its solutions keep resonating with the customer base. In a statement, CEO Julie Iskow said there was "continued demand for our broad portfolio of solutions and unified platform." A double beat on guidance, too If Workiva's guidance is any indication, the company is going to continue marching down that high-growth path. It is modeling revenue of $870 million to $873 million, which tops the consensus analyst estimate of slightly over $866 million. It's also at least 18% above the actual, full-year 2024 result. As for adjusted profitability, Workiva's forecast for the entirety of 2025 is $1.31 to $1.38 per share. Again, that exceeds both the prognosticator average of $1.04 and is well ahead of the previous year's figure of $0.94. Should you buy stock in Workiva right now? Before you buy stock in Workiva, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Workiva wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $625,254!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,090,257!* Now, it's worth noting Stock Advisor's total average return is 1,036% — a market-crushing outperformance compared to 181% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 29, 2025 Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Workiva. The Motley Fool has a disclosure policy. Why Workiva Stock Rocketed More Than 31% Higher Today was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Miami Herald
2 hours ago
- Miami Herald
Federal Reserve governor Kugler resigns, creating vacancy for Trump
Aug. 2 (UPI) -- One of the seven members of the Federal Reserve Board of Governors, Adriana Kugler, announced she is stepping down next week, creating an opening for President Donald Trump to fill. Her term was set to expire in January but Kugler said Friday she will depart in seven days. President Joe Biden appointed Kugler, a 55-year-old labor economist, in September 2023. Governors' terms are for 14 years, and Kugler filled an opening. 'The Federal Reserve does important work to help foster a healthy economy and it has been a privilege to work towards that goal on behalf of all Americans for nearly two years,' Kugler said in her resignation letter to Trump. 'I am proud to have tackled this role with integrity, a strong commitment to serving the public, and with a data-driven approach strongly based on my expertise in labor markets and inflation.' Kugler said she plans to return to teaching public policy at Georgetown University in the fall. She was a vice provost for faculty at Georgetown and earned her Ph.D. in economics at the University of California at Berkeley. 'I am especially honored to have served during a critical time in achieving our dual mandate of bringing down prices and keeping a strong and resilient labor market,' she wrote in the letter. Kugler did not vote on Wednesday when the central bank's Federal Open Market Committee kept the benchmark interest rate unchanged at a range of 4.25% to 4.5% for a fifth consecutive meeting. Two of the 11 committee members who did vote dissented, backing Trump's desire to lower rates. The 12-member committee includes the seven governors, the president of the Federal Reserve Bank of New York and four remaining 11 Reserve Bank presidents who serve one-year terms on a rotating basis. 'We just found out that I have an open spot on the Federal Reserve Board. I'm very happy about that,' Trump said late Friday before boarding Marine One. He later posted on Truth Social that Fed Chairman Jerome Powell 'should resign, just like Adriana Kugler, a Biden Appointee, resigned. She knew he was doing the wrong thing on Interest Rates. He should resign, also!' The replacement may ultimately replace Powell, whose term ends in May, though he can remain as a governor until 2028. The president appoints each of the board members and designates one to serve as chair for four years. Trump appointed Powell during his first presidency in 2018. Biden appointed him to another term as chairman. 'Trump's influence on interest rates will now be felt earlier and more strongly,' Derek Tang, an economist at LHMeyer, an economic consulting firm, told The Washington Post. Contenders to lead the Fed are National Economic Council Director Kevin Hassett, former Fed governor Kevin Warsh and Fed governor Christopher Waller, each with distinct strengths, The Washington Post reported. Trump has said he wants Scott Bessent to remain as Treasury secretary. Trump has sought to replace Powell, calling him on Truth Social 'a stubborn MORON' and 'too late' on lowering interest rates. But he can only be fired 'for cause,' such as malfeasance, neglect of duty or inefficiency, rather than disagreeing with policies. Experts say his removal could disrupt the financial markets. Copyright 2025 UPI News Corporation. All Rights Reserved.
Yahoo
2 hours ago
- Yahoo
Baxter International (BAX) Falls to New Low on Disappointing Growth Forecast
We recently published . Baxter International Inc. (NYSE:BAX) is one of the worst-performing stocks on Thursday. Baxter International dropped its share prices to a new 52-week low on Thursday, as investors soured on its lower earnings growth forecast. At intra-day trading, shares of Baxter International Inc. (NYSE:BAX) dropped to their lowest price of $21.47 before ending the day down by 22.42 percent at $21.76 apiece. In a call with analysts, Baxter International Inc. (NYSE:BAX) said it lowered its adjusted EPS to between $2.42 and $2.52 from the $2.47 to $2.55. Analysts expected $2.52 per share. 'While we never want to lower expectations, our overall objective is reducing the outlook to capture more of the potential downside risks,' Baxter International Inc. (NYSE:BAX) CFO Joel Grade was quoted as saying, underscoring the demand weakness for IV fluids. Pixabay / Public Domain In the second quarter of the year, Baxter International Inc. (NYSE:BAX) swung to a net income attributable to shareholders of $91 million from a $314 million net loss in the same period last year. Net sales inched up by 4 percent to $2.8 billion from $2.69 billion. While we acknowledge the potential of BAX as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
